Literature DB >> 15185400

Maximum-likelihood estimation of haplotype frequencies in nuclear families.

Tim Becker1, Michael Knapp.   

Abstract

The importance of haplotype analysis in the context of association fine mapping of disease genes has grown steadily over the last years. Since experimental methods to determine haplotypes on a large scale are not available, phase has to be inferred statistically. For individual genotype data, several reconstruction techniques and many implementations of the expectation-maximization (EM) algorithm for haplotype frequency estimation exist. Recent research work has shown that incorporating available genotype information of related individuals largely increases the precision of haplotype frequency estimates. We, therefore, implemented a highly flexible program written in C, called FAMHAP, which calculates maximum likelihood estimates (MLEs) of haplotype frequencies from general nuclear families with an arbitrary number of children via the EM-algorithm for up to 20 SNPs. For more loci, we have implemented a locus-iterative mode of the EM-algorithm, which gives reliable approximations of the MLEs for up to 63 SNP loci, or less when multi-allelic markers are incorporated into the analysis. Missing genotypes can be handled as well. The program is able to distinguish cases (haplotypes transmitted to the first affected child of a family) from pseudo-controls (non-transmitted haplotypes with respect to the child). We tested the performance of FAMHAP and the accuracy of the obtained haplotype frequencies on a variety of simulated data sets. The implementation proved to work well when many markers were considered and no significant differences between the estimates obtained with the usual EM-algorithm and those obtained in its locus-iterative mode were observed. We conclude from the simulations that the accuracy of haplotype frequency estimation and reconstruction in nuclear families is very reliable in general and robust against missing genotypes. Copyright 2004 Wiley-Liss, Inc.

Entities:  

Mesh:

Year:  2004        PMID: 15185400     DOI: 10.1002/gepi.10323

Source DB:  PubMed          Journal:  Genet Epidemiol        ISSN: 0741-0395            Impact factor:   2.135


  57 in total

1.  A powerful strategy to account for multiple testing in the context of haplotype analysis.

Authors:  Tim Becker; Michael Knapp
Journal:  Am J Hum Genet       Date:  2004-07-30       Impact factor: 11.025

2.  Impact of genotyping errors on type I error rate of the haplotype-sharing transmission/disequilibrium test (HS-TDT).

Authors:  Michael Knapp; Tim Becker
Journal:  Am J Hum Genet       Date:  2004-03       Impact factor: 11.025

3.  Accurate haplotype inference for multiple linked single-nucleotide polymorphisms using sibship data.

Authors:  Peng-Yuan Liu; Yan Lu; Hong-Wen Deng
Journal:  Genetics       Date:  2006-06-18       Impact factor: 4.562

4.  The human GIMAP5 gene has a common polyadenylation polymorphism increasing risk to systemic lupus erythematosus.

Authors:  Anna Hellquist; Marco Zucchelli; Katja Kivinen; Ulpu Saarialho-Kere; Sari Koskenmies; Elisabeth Widen; Heikki Julkunen; Andrew Wong; Marja-Liisa Karjalainen-Lindsberg; Tiina Skoog; Johanna Vendelin; Deborah S Cunninghame-Graham; Timothy J Vyse; Juha Kere; Cecilia M Lindgren
Journal:  J Med Genet       Date:  2007-01-12       Impact factor: 6.318

5.  DIRAS2 is associated with adult ADHD, related traits, and co-morbid disorders.

Authors:  Andreas Reif; T Trang Nguyen; Lena Weissflog; Christian P Jacob; Marcel Romanos; Tobias J Renner; Henriette N Buttenschon; Sarah Kittel-Schneider; Alexandra Gessner; Heike Weber; Maria Neuner; Silke Gross-Lesch; Karin Zamzow; Susanne Kreiker; Susanne Walitza; Jobst Meyer; Christine M Freitag; Rosa Bosch; Miquel Casas; Nuria Gómez; Marta Ribasès; Mónica Bayès; Jan K Buitelaar; Lambertus A L M Kiemeney; J J Sandra Kooij; Cees C Kan; Martine Hoogman; Stefan Johansson; Kaya K Jacobsen; Per M Knappskog; Ole B Fasmer; Phil Asherson; Andreas Warnke; Hans-Jörgen Grabe; Jessie Mahler; Alexander Teumer; Henry Völzke; Ole N Mors; Helmut Schäfer; Josep Antoni Ramos-Quiroga; Bru Cormand; Jan Haavik; Barbara Franke; Klaus-Peter Lesch
Journal:  Neuropsychopharmacology       Date:  2011-07-13       Impact factor: 7.853

6.  Three microsatellites from the T1DGC MHC data set show highly significant association with type 1 diabetes, independent of the HLA-DRB1, -DQA1 and -DQB1 genes.

Authors:  M C Eike; K Humphreys; T Becker; M Olsson; B A Lie
Journal:  Diabetes Obes Metab       Date:  2009-02       Impact factor: 6.577

7.  Maternal transmission effects of the PAX genes among cleft case-parent trios from four populations.

Authors:  Jae Woong Sull; Kung-Yee Liang; Jacqueline B Hetmanski; Margaret Daniele Fallin; Roxanne G Ingersoll; Jiwan Park; Yah-Huei Wu-Chou; Philip K Chen; Samuel S Chong; Felicia Cheah; Vincent Yeow; Beyoung Yun Park; Sun Ha Jee; Ethylin W Jabs; Richard Redett; Alan F Scott; Terri H Beaty
Journal:  Eur J Hum Genet       Date:  2009-01-14       Impact factor: 4.246

8.  Association between genes on chromosome 4p16 and non-syndromic oral clefts in four populations.

Authors:  Roxann G Ingersoll; Jacqueline Hetmanski; Ji-Wan Park; M Daniele Fallin; Iain McIntosh; Yah-Huei Wu-Chou; Philip K Chen; Vincent Yeow; Samuel S Chong; Felicia Cheah; Jae Woong Sull; Sun Ha Jee; Hong Wang; Tao Wu; Tanda Murray; Shangzhi Huang; Xiaoqian Ye; Ethylin Wang Jabs; Richard Redett; Gerald Raymond; Alan F Scott; Terri H Beaty
Journal:  Eur J Hum Genet       Date:  2010-01-20       Impact factor: 4.246

9.  Likelihood-based association analysis for nuclear families and unrelated subjects with missing genotype data.

Authors:  Frank Dudbridge
Journal:  Hum Hered       Date:  2008-03-31       Impact factor: 0.444

10.  Influence of a latrophilin 3 (LPHN3) risk haplotype on event-related potential measures of cognitive response control in attention-deficit hyperactivity disorder (ADHD).

Authors:  Andreas J Fallgatter; Ann-Christine Ehlis; Thomas Dresler; Andreas Reif; Christian P Jacob; Mauricio Arcos-Burgos; Maximilian Muenke; Klaus-Peter Lesch
Journal:  Eur Neuropsychopharmacol       Date:  2012-12-12       Impact factor: 4.600

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.